clinical trials for tirzepatide Other with 86-88 EASD 2023: meta-analysis shows tirzepatide

Compare that to semaglutides STEP-1 trial results of 14.9 percent, or Saxenda (liraglutide) at roughly 8 percent

Patients on 15 mg lost approximately 6 percentage points more body weight on average than those on 5 mg

J Endocrinol 264(2):e240210 McIntyre RS, Mansur RB, Rosenblat JD, Rhee TG, Cao B, Teopiz KM, Wong S, Le GH, Ho R, Kwan ATH (2025) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)

Outside Magazine

At La Jolla Recovery, we work daily with individuals whose substance use and physical health challenges are deeply intertwined

Ipamorelin is the most selective GHRP, producing clean GH release without affecting cortisol, prolactin, or appetite, but with lower acute potency